ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,358 | -12.6% | 4,798 | -33.7% | 0.00% | 0.0% |
| Q1 2023 | $2,697 | -97.6% | 7,239 | +1872.5% | 0.00% | – |
| Q3 2021 | $111,000 | +0.9% | 367 | 0.0% | 0.00% | – |
| Q2 2021 | $110,000 | -84.5% | 367 | -91.7% | 0.00% | -100.0% |
| Q4 2019 | $711,000 | +290.7% | 4,432 | +176.3% | 0.00% | +100.0% |
| Q3 2019 | $182,000 | +1416.7% | 1,604 | +1504.0% | 0.00% | – |
| Q1 2019 | $12,000 | -85.9% | 100 | -88.8% | 0.00% | – |
| Q4 2018 | $85,000 | – | 893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |